TORONTO, July 15 /CNW/ - Dalton Pharma Services is pleased to announce
the expansion of its Contract Analytical Services with the commissioning of
two validated LC-MS/MS instruments which have been qualified for GMP testing
of pharmaceutical products. The new equipment will assist in the
identification, quantification of related substances, pharmaceutical
degradation products and impurities to support the preparation of registration
dossiers for clients' drug development programs.
"Our commitment to accelerate the drug discovery and development process
continues as we add to our state-of-the-art instrumentation to support GMP API
synthesis, sterile dose formulation and sterile fill, method validation and
other outsourced analytical projects including stability studies,
bioanalytical development and analysis," said Peter Pekos, President and CEO.
Dalton continues to develop and grow its analytical capabilities to enhance
it's commitment to quality, responsiveness, flexibility and innovation through
the supply of unparalleled contract pharmaceutical development services.
About Dalton Pharma Services
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health
Canada approved contract pharmaceutical manufacturer that supplies chemistry
and analytical services to the biotechnology and pharmaceutical industries in
the areas of chemistry, medicinal chemistry and fine chemical manufacture.
Dalton provides cGMP manufacturing and sterile filling services to its
customers at any stage of the regulatory process (Phase I, II, III or
commercial). In its state of the art cGMP facilities, Dalton produces active
pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts
sterile fills to produce batches of finished drug product in vials or
syringes, either aseptically filled or terminally sterilized, under fully
validated conditions. In addition, Dalton's analytical chemistry laboratory
offers method development, validation and ICH stability programs to its
For further information:
For further information: Peter Pekos, President & CEO, Dalton Pharma
Services, Tel: (416) 661-2102, Fax: (416) 661-2108